Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Retail Press Releases.
Press releases published on July 7, 2025
SELLAS Life Sciences Appoints Linghua Wang, MD, PhD, to Scientific Advisory Board
GlobeNewswire
·
July 7, 2025
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
HUHUTECH International Group Inc. to Participate in the ORY APAC-US Conference 2025 in Singapore
GlobeNewswire
·
July 7, 2025
Wuxi, China, July 07, 2025 (GLOBE NEWSWIRE) -- HUHUTECH International Group Inc. (Nasdaq: HUHU) (the “Company” or “HUHUTECH”), a professional provider of factory facility management and monitoring systems, announced today that the Company will participate …
NRSInsights’ June 2025 Retail Same-Store Sales Report
GlobeNewswire
·
July 7, 2025
June same-store sales increased 3.5% year-over-year NEWARK, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- NRSInsights, a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) point-of-sale (POS …
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
GlobeNewswire
·
July 7, 2025
Includes Conduit’s first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 and AZD5658 Patents derived from AI-led analysis conducted in partnership with Sarborg Limited NAPLES, Fla. and CAMBRIDGE, United …
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
GlobeNewswire
·
July 7, 2025
Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07, 2025 ( …
INVESTOR ALERT: Investigation of RH (RH) Announced by Holzer & Holzer, LLC
GlobeNewswire
·
July 7, 2025
ATLANTA, Ga., July 07, 2025 (GLOBE NEWSWIRE) -- Holzer …
Expert’s Presentation Exposes Massive Federal Resource That Could Quietly Fund Trump’s Ambitious New Agenda
GlobeNewswire
·
July 7, 2025
Baltimore, MD, July 07, 2025 (GLOBE NEWSWIRE) -- A released presentation by economic strategist Jim Rickards is drawing fresh attention just as President Trump prepares to introduce his most sweeping economic legislation to date—a bill insiders are …
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
GlobeNewswire
·
July 7, 2025
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has completed …
REsimpli Launches Game-Changing AI-Powered CRM Tools for Real Estate Investors
GlobeNewswire
·
July 7, 2025
Highland, Indiana, July 07, 2025 (GLOBE NEWSWIRE) -- REsimpli, a leading all-in-one AI CRM for Real Estate Investors, is thrilled to announce the launch of its REsimpli 5.0 release that introduces 8 powerful AI Agent tools and a List Pulling Feature that …
Medicines for Poland Announces: Without pharmaceutical factories Europe will lose any war
GlobeNewswire
·
July 7, 2025
BRUSSELS, July 07, 2025 (GLOBE NEWSWIRE) -- The need to establish a fund under the EU budget to support the production of critical medicines in Europe is a conclusion drawn from an analysis of the impact of the war on the availability of medicines in …
Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro™ (repotrectinib)
GlobeNewswire
·
July 7, 2025
LOUISVILLE, Ky., July 07, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol Myers Squibb to its comprehensive list of limited distribution therapies. Augtyro …
FuelCell Energy CEO Jason Few Applauds “One Big Beautiful Bill Act” as Catalyst for U.S. Clean Energy Leadership
GlobeNewswire
·
July 7, 2025
DANBURY, Conn., July 07, 2025 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq: FCEL) President and CEO Jason Few has issued a statement praising the “One Big Beautiful Bill Act” (OBBBA) for its direct support of the fuel cell industry and its role in …
Unisync announces the retirement of Douglas F. Good as CEO
GlobeNewswire
·
July 7, 2025
TORONTO, July 07, 2025 (GLOBE NEWSWIRE) -- Unisync Corp. (“Unisync”) (TSX: UNI) (OTC: USYNF) today announced that Douglas F. Good, the Company’s Chief Executive Officer, will retire as CEO and a director effective July 15, 2025. Chairman Tim Gu will assume …
At the Yacht Club de Monaco nautical prototypes and laboratories come together for the zero emissions goal
GlobeNewswire
·
July 7, 2025
MONACO, July 07, 2025 (GLOBE NEWSWIRE) -- At the Monaco Energy Boat Challenge, new technologies to reach sustainability in the maritime transport sector take center stage with the SeaLab Class and the OpenSea Class. “Vita has been coming to the Monaco …
Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis
GlobeNewswire
·
July 7, 2025
-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new …
BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development
GlobeNewswire
·
July 7, 2025
RESEARCH TRIANGLE PARK, N.C., July 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Babar Ghias as chief financial officer (CFO) and head of corporate development. Mr. Ghias joins BioCryst from …
Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia
GlobeNewswire
·
July 7, 2025
Breakthrough Therapy designation based on interim clinical data from Phase I/II trials showing clinically meaningful improvements in cardiac biomarkers and functional measures LX2006 also selected for FDA Chemistry, Manufacturing, and Controls Development …
At the Yacht Club de Monaco, a discussion on alternative fuels for the future of the maritime sector
GlobeNewswire
·
July 7, 2025
MONACO, July 07, 2025 (GLOBE NEWSWIRE) -- Exploring the potential of alternative fuels in the maritime sector. During the days of the 12th Monaco Energy Boat Challenge (1-5 July), at the Alternative Fuels Conference on Friday morning, different actors …
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER
GlobeNewswire
·
July 7, 2025
- Fibrolamellar hepatocellular carcinoma (FLC) has no approved treatment and occurs mostly in adolescents and young adults - KUALA LUMPUR, Malaysia, July 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: …
CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT
GlobeNewswire
·
July 7, 2025
Kuala Lumpur, Malaysia, July 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it has entered into an …